HomeMedical SpecialtiesDiseasesGestational diabetes in subsequent pregnancies significantly increases risk of type 2 diabetes

Gestational diabetes in subsequent pregnancies significantly increases risk of type 2 diabetes

Published on

ecent study reveals that the risk of developing type 2 diabetes is increased in women who first get gestational diabetes during a second pregnancy, and that it increases even more for those who get it during two consecutive pregnancies.

One in 10 Canadian adults has type 2 diabetes, a disease that damages blood vessels and can lead to heart disease, stroke, kidney disease and even blindness. 

Women with gestational diabetes – temporary diabetes during pregnancy – are at higher risk for future type 2 diabetes later in life. But from one pregnancy to the next, how does this risk evolve? A new study from the Research Institute of McGill University Health Centre (RI-MUHC) shows that women who have gestational diabetes for the first time in a second pregnancy have a 76 per cent higher risk of future type 2 diabetes than women with gestational diabetes in the first pregnancy but not in the second. Women with gestational diabetes in both pregnancies are at the highest risk, more than 3.5 times higher than those with gestational diabetes only in their first pregnancy. The study authors hope that the results of the study recently published in JAMA Network Open will enable women to benefit from personalized advice to reduce their risk of developing type 2 diabetes. 

Women with gestational diabetes – temporary diabetes during pregnancy – are at higher risk for future type 2 diabetes later in life.

“Around 10 per cent of pregnancies are affected by gestational diabetes overall. Our study shows that future diabetes risk differs in relationship to which pregnancy is affected by gestational diabetes and how many gestational diabetes pregnancies there are. We can help mothers personalize risk estimates with this and other information, so that they can make informed choices about when and how to take action on prevention,” says Dr. Kaberi Dasgupta, senior author of the study and Senior Scientist in the Metabolic Disorders and Complications Program at the RI-MUHC

A detailed portrait to inspire action

Using data from Quebec health administrative and birth and death registries, the researchers built a study group of 431,980 women with two deliveries between 1990 and 2012. They did not have diabetes before or between their pregnancies. The researchers looked at whether they had developed diabetes by 2019. 

More than 10,000 women had gestational diabetes only in their first pregnancy, more than 16,000 had it only in their second, and more than 8,000 had it in both pregnancies (respectively, 10,920 women (2.5%), 16,145 women (3.7%) and 8255 women (1.9%)).  Overall, more than 12,000 developed type 2 diabetes. 

Compared with women who had never had gestational diabetes, those who had gestational diabetes during their first pregnancy had over 4 times the risk of future type 2 diabetes (4,35), those with gestational diabetes in the second pregnancy only had more than 7.5 times the risk (7,68), and those with gestational diabetes in both pregnancies had a nearly 16 times higher risk (15,8). 

The importance of healthy lifestyle habits 

“Our results suggest that women who had gestational diabetes in their first pregnancy, but not in their second, were probably able to change their eating habits and increase their physical activity between the two pregnancies. We can now tell them that they have also lowered their risk of future diabetes, which could encourage them to maintain their healthy life habits,” explains Joseph Mussa, first author of the paper and PhD candidate in the Department of Epidemiology and Biostatistics at McGill University. 

“On the other hand, women diagnosed with gestational diabetes in a second pregnancy have moved to an increased level of risk. We need to help them manage this risk. We also need to provide women who have had two occurrences of gestational diabetes with urgent support to improve their health and reduce their risk,” adds Dr. Dasgupta, who is also a professor at McGill University’s Faculty of Medicine and Health Sciences and an internist at the MUHC.

Other factors at play

The researchers performed several analyses, taking into account various known risk factors for type 2 diabetes. As expected, having gestational hypertension, giving birth to a baby with a high weight for gestational age, or having a partner with diabetes, were associated with an increased risk of the mother developing type 2 diabetes. The risk was also increased for women with mood disorders, drug or alcohol addiction, thyroid problems, arthritis or respiratory problems.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

RSV hospital admissions for children more than doubled in 2022/23

New Canadian research shows pediatric RSV hospitalizations more than doubled in 2022/23 compared to pre-pandemic levels, with significant increases across all age groups and nearly one-quarter requiring ICU care. Infants under six months remain the most vulnerable, accounting for the majority of severe cases. The surge is linked to disrupted virus exposure during COVID-19, highlighting the importance of new prevention strategies, including maternal vaccination and infant immunoprophylaxis.

Navigating breastfeeding after spinal cord injury

HN Summary • New research shows spinal cord injuries can disrupt breastfeeding due to physiological...

First-in-Canada case of sustained HIV remission

HN Summary • A first-in-Canada case shows a patient achieving sustained HIV remission following a...

UHN researchers investigate new therapies as colon cancer rises among young patients

HN Summary • Colorectal cancer is rising among younger adults, prompting UHN researchers to investigate...

HHS lung cancer patient thrives thanks to research trial

HN Summary • A Nurse Practitioner (NP) pilot in Niagara Health’s ED has significantly reduced...

New Research at University of Alberta Advances Fight Against Parkinson’s Disease

Researchers at the University of Alberta are reporting new progress in understanding and potentially...